Claritev Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Travis S. Dalton
- Full Time Employees
- 3,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 7900 Tysons One Place McLean VA United States of America 22102
- IPO Date
- Apr 3, 2020
- CIK
- 0001793229
- Website
- claritev.com
- Similar Companies
- Business
- Claritev Corporation (NYSE: CTEV), formerly known as MultiPlan Corporation, provides data analytics and technology-enabled cost management, payment integrity, and revenue integrity solutions to the healthcare industry primarily in the United States; its core offerings include analytics-based services utilizing data-driven algorithms to detect claims overcharges, negotiate reimbursements, and recommend fair market value pricing; network-based services delivering contracted discounts with healthcare providers and outsourced network development and management; payment and revenue integrity services that identify improper charges, recover underpaid premiums, and ensure billing accuracy; and data and decision science services applying predictive and prescriptive analytics to optimize benefit plan design, clinical outcomes, and total cost of care. The company serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored health plans, third-party administrators, self-insured employers, property and casualty insurers, bill review companies, over 700 healthcare payors, 100,000 employers, 60 million consumers, and 1.4 million contracted providers through its enterprise platform powered by AI, machine learning, and over 40 years of claims processing experience. Founded in 1980 and headquartered in New York, New York, with principal executive offices in McLean, Virginia, Claritev rebranded from MultiPlan in February 2025, changed its stock ticker to CTEV effective February 28, 2025, and reported a return to revenue growth in the second quarter of 2025 with multi-year client renewals, new enterprise subscription deals, and expanded partnerships across verticals including record-sized wins and new logos in key market segments.
Company News
Claritev (NYSE:CTEV) SVP Sells $138,383.72 in Stock
Claritev Appoints Jennifer Main to its Board of Directors
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call
Reviewing Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR)
Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test
Claritev (NYSE:CTEV) CFO Douglas Michael Garis Sells 9,025 Shares
Claritev Selected by GDIT to Support CDC's World Trade Center Health Program
Claritev (NYSE:CTEV) Receives Consensus Rating of “Moderate Buy” from Brokerages
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100
Claritev Releases 2025 Corporate Responsibility Report
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Claritev Appoints Ben Letham to its Board of Directors
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home
Claritev Corporation Announces Participation in Upcoming Events
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Claritev Analysts Raise Their Forecasts Following Q2 Earnings
Claritev Q2 Earnings Call Highlights
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript
Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates
Claritev Corporation Reports Second Quarter 2026 Results